HomePDSB • NASDAQ
add
PDS Biotechnology Corp
Previous close
$1.02
Day range
$1.00 - $1.05
Year range
$0.70 - $2.20
Market cap
52.90M USD
Avg Volume
1.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.14M | -20.03% |
Net income | -9.01M | 16.01% |
Net profit margin | — | — |
Earnings per share | -0.19 | 34.48% |
EBITDA | -8.13M | 20.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.20M | -47.34% |
Total assets | 34.71M | -33.83% |
Total liabilities | 25.25M | -17.07% |
Total equity | 9.45M | — |
Shares outstanding | 48.98M | — |
Price to book | 5.10 | — |
Return on assets | -54.14% | — |
Return on capital | -65.73% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -9.01M | 16.01% |
Cash from operations | -5.92M | 26.05% |
Cash from investing | — | — |
Cash from financing | 241.20K | 1,301.05% |
Net change in cash | -5.67M | 28.91% |
Free cash flow | -3.47M | 21.12% |
About
Founded
2005
Website
Employees
24
